Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TMN-1
- Development stage
- Unknown
- Administration
- Oral
01
Overview
**TMN-1** is an orally administered traditional Chinese herbal medicine mixture used in Taiwan as a nonhormonal intervention for menopausal hot flashes. It combines the classical multi-herb formulas Chia-Wei-Hsiao-Yao-San, Chih-Po-Ti-Huang-Wan, and Hsiang-Sha-Liu-Chun-Tzu-Tang. Its molecular targets and pharmacologic mechanism have not been established; it was evaluated in a multicenter prospective observational study sponsored by National Taiwan University Hospital for menopausal hot flashes and climacteric symptoms. ([clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00275964))
- Other names
- CHIA-WEI-HSIAO-YAO-SAN + CHIH-PO-TI-HUANG-WAN + HSIANG-SHA-LIU-CHUN-TZU-TANGJia-Wei-Xiao-Yao-San + Zhi-Bai-Di-Huang-Wan + Xiang-Sha-Liu-Jun-Zi-Tang
Beyond the preview
Go deeper on TMN-1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TMN-1.